What if male contraception were as simple as getting a flu shot?

The future of male contraception.

Contraline has developed a new contraceptive for men called Echo-V.

It's a polymer gel implanted non-surgically into the vas deferens. The first long-lasting, non-hormonal, and reversible male birth control.

Learn how it works »

"Men want to help female partners out. Times are changing."

Our Mission

The demand for better birth control has never been higher. Contraline aims to provide men with a safe, effective, and appealing contraceptive option.

Meet Our Team

View all team members

Kevin Eisenfrats

Co-Founder and Chief Executive Officer

Kevin Eisenfrats graduated from the University of Virginia with a degree in Nanomedicine Engineering. Having conceived the idea behind Contraline, Mr. Eisenfrats has won numerous university and national awards for the invention. Mr. Eisenfrats spearheads the commercialization and business development of Contraline.

Dr. John Herr, Ph.D.

In memory of our Co-Founder

Dr. Herr was a Professor of Cell Biology, Urology, and Biomedical Engineering at the University of Virginia. He was also Director of the Center for Research in Contraceptive and Reproductive Health and renowned expert in reproductive biology. Dr. Herr founded four biotechnology companies before co-founding Contraline.


Contraline Secures $2.25 M in Seed Financing

CHARLOTTESVILLE, Virginia — Contraline, a biotechnology company developing a novel male contraceptive, announced it has raised $2.25 million in Seed funding. The round was led by San Francisco-based venture capital firm, Founders Fund, with investments also coming from Center for Innovative Technology, Abstract Ventures, Afton Scientific, and angel investors including Jaffray Woodriff and Jason Calacanis. […]